Page last updated: 2024-08-22

molybdenum and navitoclax

molybdenum has been researched along with navitoclax in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chandel, NS; Diebold, LP; Glasauer, A; Mazar, AP; Sena, LA1
Briehl, MM; Hart, MR; Lee, K; Mazar, AP; Tome, ME1

Other Studies

2 other study(ies) available for molybdenum and navitoclax

ArticleYear
Targeting SOD1 reduces experimental non–small-cell lung cancer.
    The Journal of clinical investigation, 2014, Volume: 124, Issue:1

    Topics: Aniline Compounds; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Hydrogen Peroxide; Lung Neoplasms; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molybdenum; Myeloid Cell Leukemia Sequence 1 Protein; Sulfonamides; Superoxide Dismutase; Superoxide Dismutase-1; Tumor Burden; Tumor Suppressor Protein p53

2014
The copper chelator ATN-224 induces caspase-independent cell death in diffuse large B cell lymphoma.
    International journal of oncology, 2014, Volume: 45, Issue:1

    Topics: Aniline Compounds; Apoptosis; Apoptosis Inducing Factor; Caspases; Cell Line, Tumor; Chelating Agents; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Mitochondria; Molybdenum; Sulfonamides

2014